<Home — Psychoactive Plant Database



  Psychoactive Plant Database - Neuroactive Phytochemical Collection





Worldwide, there are plants known as psychoactive plants that naturally contain psychedelic active components. They have a high concentration of neuroprotective substances that can interact with the nervous system to produce psychedelic effects. Despite these plants' hazardous potential, recreational use of them is on the rise because of their psychoactive properties. Early neuroscience studies relied heavily on psychoactive plants and plant natural products (NPs), and both recreational and hazardous NPs have contributed significantly to the understanding of almost all neurotransmitter systems. Worldwide, there are many plants that contain psychoactive properties, and people have been using them for ages. Psychoactive plant compounds may significantly alter how people perceive the world.

 

 

1. Can J Neurol Sci. 2024 Nov 7:1-23. doi: 10.1017/cjn.2024.285. Online ahead of print. Updated Canadian Headache Society Migraine Prevention Guideline with Systematic Review and Meta-analysis. Medrea I(1)(2), Cooper P(3), Langman M(3), Sandoe CH(2), Amoozegar F(4), Hussain WM(5), Bradi AC(6), Dawe J(7), Guay M(8), Perreault F(9), Reid S(10), Todd C(2), Skidmore B(11), Christie SN(6). Author information: (1)Division of Neurology, SUNY Upstate Medical University, Syracuse, NY, USA. (2)Women's College Hospital, Division of Neurology, University of Toronto, Toronto, ON, Canada. (3)London Health Sciences Centre, Division of Neurology, University of Western Ontario, London, ON, Canada. (4)South Health Campus, Alberta Health Services, Division of Neurology, University of Calgary, Calgary, AB, Canada. (5)Kaye Edmonton Clinic, Division of Neurology, University of Alberta, Edmonton, AB, Canada. (6)Ottawa Hospital, Division of Neurology, University of Ottawa, Ottawa, ON, Canada. (7)QEII Health Sciences Centre, Department of Anesthesia, Pain Management & Perioperative Medicine, Dalhousie University, Halifax, NS, Canada. (8)St. Joseph's Health Care Hamilton West 5th Campus, Division of Neurology, McMaster University, Hamilton, ON, Canada. (9)CHUM, Division of Neurology, University of Montreal, Montreal, QC, Canada. (10)Kingston General Hospital, Division of Neurology, Queen's University, Kingston, ON, Canada. (11)Independent Information Specialist, Ottawa, ON, Canada. OBJECTIVE: We have updated the migraine prevention guideline of the Canadian Headache Society from 2012, as there are new therapies available, and additionally, we have provided guidelines for the prevention of chronic migraine, which was not addressed in the previous iteration. METHODS: We undertook a systematic review to identify new studies since the last guideline. For studies identified, we performed data extraction and subsequent meta-analyses where possible. We composed a summary of the evidence found and undertook a modified Delphi recommendation process. We provide recommendations for treatments identified and additionally expert guidance on the use of the treatments available in important clinical situations. RESULTS: We identified 61 studies that were included in this evidence update and identified 16 therapies we focused on. The anti-calcitonin gene-related peptide (CGRP) agents were approved by Health Canada between 2018 and 2024 and provide additional options for episodic and chronic migraine prevention. We also summarize evidence for the use of propranolol, topiramate and onabotulinumtoxinA in addition to anti-CGRP agents as treatments for chronic migraine. We have downgraded topiramate to a weak recommendation for use and gabapentin to a weak recommendation against its use in episodic migraine. We have weakly recommended the use of memantine, levetiracetam, enalapril and melatonin in episodic migraine. CONCLUSION: Based on the evidence synthesis, we provide updated recommendations for the prevention of episodic and chronic migraine utilizing treatments available in Canada. We additionally provided expert guidance on their use in clinical situations. DOI: 10.1017/cjn.2024.285 PMID: 39506371 2. Physiol Plant. 2024 Nov-Dec;176(6):e14592. doi: 10.1111/ppl.14592. Exogenous melatonin promotes salt tolerance in smooth bromegrass seedlings: physiological, transcriptomic, and metabolomic evidence. Song W(#)(1)(2)(3), Wang J(#)(1)(2)(3), Wang X(1)(2)(3), Xi J(1)(2)(3), Cai W(1)(2)(3), Ma X(1)(2)(3), Zhang J(1)(2)(3), Fu B(1)(2)(3), Gao X(1)(2)(3). Author information: (1)College of Forestry and Prataculture, Ningxia University, Yinchuan, Ningxia, China. (2)Ningxia Grassland and Animal Husbandry Engineering Technology Research Center, Yinchuan, Ningxia, China. (3)Key Laboratory for Model Innovation in Forage Production Efficiency, Ministry of Agriculture and Rural Affairs, Yinchuan, Ningxia, China. (#)Contributed equally Soil salinization, which severely limits crop yield and quality, has become a global environmental and resource issue. Melatonin plays an important role in plant responses to salt stress. Smooth bromegrass is an important forage with excellent feed value and is widely grown in northern and north-west China for pasture and sand binding. However, the physiological and molecular mechanisms underlying exogenous melatonin regulation of salt stress in smooth bromegrass are not clear. This study compared the phenotype, physiological, transcriptome, and metabolome profiles of two varieties with contrasting salt tolerance attributes under salt and melatonin treatment. After melatonin treatment, the catalase (CAT) and ascorbate peroxidase (APX) activity, proline content, actual photochemical efficiency (Y(II)), relative water content, and fresh weight above ground were significantly higher than under salt treatment, while relative conductivity, H2O2 content, and Na+/K+ ratio were significantly lower than salt treatment. The transcriptome and metabolite profiling analysis of smooth bromegrass seedlings treated without melatonin under salt stress identified the presence of 22522 differentially expressed genes (DEGs) and 862 differentially expressed metabolites (DEMs) in SS, 17809 DEGs and 812 DEMs in ST, while treated with melatonin under salt stress identified the presence of 7033 DEGs and 177 DEMs in SS, 2951 DEGs and 545 DEMs in ST. Furthermore, in response to salt stress, melatonin may be involved in regulating the correlation between DEGs and DEMs in flavonoid biosynthesis, proline biosynthesis, and melatonin biosynthesis. Moreover, melatonin participated in mediating melatonin biosynthesis pathways and affected the expression of ASMT in response to salt stress. © 2024 Scandinavian Plant Physiology Society. DOI: 10.1111/ppl.14592 PMID: 39506145 [Indexed for MEDLINE] 3. Life Sci. 2024 Nov 4:123200. doi: 10.1016/j.lfs.2024.123200. Online ahead of print. Melatonin protects against particulate matter-induced ovarian dysfunction by activating the Nrf2 signaling pathway to alleviate ferroptosis. Zhang X(1), Man X(2), Zhang Q(3), Zhu L(4), Chen L(1), Zhu C(1), Ci X(4), Yu X(5). Author information: (1)Department of Reproductive Medicine, Jilin Provincial Key Laboratory of Women's Reproductive Health, The First Hospital of Jilin University, Changchun, Jilin, China. (2)Department of Oncologic Gynecology, The First Hospital of Jilin University, Changchun, Jilin, China. (3)Department of Intensive Care Unit, The First Hospital of Jilin University, Changchun, Jilin, China. (4)Department of Reproductive Medicine, Jilin Provincial Key Laboratory of Women's Reproductive Health, The First Hospital of Jilin University, Changchun, Jilin, China; Institute of Translational Medicine, The First Hospital of Jilin University, Changchun, China. (5)Department of Reproductive Medicine, Jilin Provincial Key Laboratory of Women's Reproductive Health, The First Hospital of Jilin University, Changchun, Jilin, China. Electronic address: yuxiaow@jlu.edu.cn. Accumulating evidence suggests that exposure to ambient airborne PM2.5 increases the risk of primary ovarian insufficiency (POI). However, whether ferroptosis, a newly discovered type of cell death involved in PM2.5-induced lung injury and fibrosis, is involved in PM2.5-induced POI has not been determined. This study aimed to verify the involvement of PM2.5-induced ferroptosis in ovarian dysfunction and further demonstrate that melatonin inhibits ferroptosis by activating the Nrf2 signaling pathway to ameliorate POI in vivo and in vitro. In our study, PM2.5 promoted iron accumulation and induced lipid peroxidation, thus contributing to ferroptosis in KGN cells and ovaries. However, these effects were eliminated and enhanced in Nrf2-overexpressing and Nrf2-knockdown cells, respectively. In addition, melatonin and ferrostatin-1 (Fer-1) inhibited ferroptosis by activating the NRF2 signaling pathway, as evidenced by the silencing of Nrf2 in vivo and in vitro. Mechanistically, Nrf2-knockout mice were more susceptible to ferroptosis and PM2.5-induced POI than control mice. Moreover, melatonin suppressed changes in morphological and biochemical indicators related to ferroptosis, such as MDA and GSH depletion and GPX4 and XCT downregulation, by enhancing Nrf2 signaling. Here, we first reported that PM2.5 triggered ferroptosis by increasing ROS levels, lipid peroxidation and glutathione depletion. Notably, melatonin significantly decreased ferroptosis levels and improved ovarian function by activating the NRF2 signaling pathway in vivo and in vitro. Copyright © 2024. Published by Elsevier Inc. DOI: 10.1016/j.lfs.2024.123200 PMID: 39505297 Conflict of interest statement: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. 4. Stem Cell Rev Rep. 2024 Nov 6. doi: 10.1007/s12015-024-10819-y. Online ahead of print. Enhancing Late Retinopathy of Prematurity Outcomes with Fresh Bone Marrow Mononuclear Cells and Melatonin Combination Therapy. Mirnia K(1), Bitaraf M(2), Namakin K(2), Azimzadeh A(2), Tanourlouee SB(3)(4), Zolbin MM(5)(6), Masoumi A(7), Kajbafzadeh AM(2). Author information: (1)Pediatrics Center of Excellence, Department of Neonatology, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran. (2)Pediatric Urology and Regenerative Medicine Research Center, Pediatric Center of Excellence, Gene, Cell & Tissue Research Institute Tehran University of Medical Sciences, Tehran, Iran. (3)Pediatric Urology and Regenerative Medicine Research Center, Pediatric Center of Excellence, Gene, Cell & Tissue Research Institute Tehran University of Medical Sciences, Tehran, Iran. Behboodisaman09@gmail.com. (4)Children's Medical Center, Gharib st., Keshavarz blvd., Tehran, 419733151, Iran. Behboodisaman09@gmail.com. (5)Pediatric Urology and Regenerative Medicine Research Center, Pediatric Center of Excellence, Gene, Cell & Tissue Research Institute Tehran University of Medical Sciences, Tehran, Iran. mmajidizolbin@sina.tums.ac.ir. (6)Children's Medical Center, Gharib st., Keshavarz blvd., Tehran, 419733151, Iran. mmajidizolbin@sina.tums.ac.ir. (7)Ophthalmology Department and Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran. INTRODUCTION: Retinopathy of prematurity (ROP) is a vasoproliferative disease affecting premature neonates with life-lasting impacts. This study aims to investigate the long-term functional outcomes and alterations in neural retina architecture following the intravitreal transplantation of bone marrow mononuclear cells (BMMNC) in the rat models of ROP, and to evaluate the effect of adjunctive therapy with melatonin. METHODS: 32 neonate rats were employed. The ROP model was developed in 10 neonatal rats, and two were assigned as control. The ROP models received BMMNC suspension, containing 1.2 × 105 cells, in their right eye, and normal saline in left at p12. Five ROP rats received 12.5 mg/kg melatonin orally for five days (p12 to p17). Optical coherence tomography (OCT) and electroretinography (ERG) were performed on p47. Eyes were then harvested on p47, and after six months for histology, immunofluorescence (anti-calbindin, anti-PKC, and anti-Brn3), and immunohistochemistry (synaptophysin). RESULTS: Cell therapy alone and with melatonin increased retinal thickness, and improved oscillatory potentials on ERG. Combination therapy increased horizontal and retinal ganglion cell populations. All treatments improved synaptic maturity in the inner plexiform layer, but only combination therapy was effective on the outer plexiform layer. CONCLUSION: Melatonin and BMMNCs combination therapy effectively ameliorates retinal structural and functional deficits at later ROP stages, without causing severe adverse effects. It significantly increases the survival of post-receptor retinal neurons and preserves retinal synaptic structures in the long term, highlighting the promising potential of this novel combination therapy approach to minimize visual deficits in ROP patients. © 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. DOI: 10.1007/s12015-024-10819-y PMID: 39503829 5. Food Chem. 2024 Oct 18;464(Pt 2):141661. doi: 10.1016/j.foodchem.2024.141661. Online ahead of print. Melatonin treatment maintains the quality properties and storability of carambola fruit by modulating energy metabolism. Hu T(1), Zheng S(1), Liu Q(1), Li M(1), Chen J(1), Zhang H(1), Lin M(2), Lin H(3), Chen Y(4). Author information: (1)Institute of Postharvest Technology of Agricultural Products, College of Food Science, Fujian Agriculture and Forestry University, Fuzhou, Fujian 350002, China; Key Laboratory of Postharvest Biology of Subtropical Special Agricultural Products, Fujian Province University, Fuzhou, Fujian 350002, China. (2)Food Science Program, Division of Food, Nutrition & Exercise Sciences, University of Missouri, Columbia, MO 65211, United States. (3)Institute of Postharvest Technology of Agricultural Products, College of Food Science, Fujian Agriculture and Forestry University, Fuzhou, Fujian 350002, China; Key Laboratory of Postharvest Biology of Subtropical Special Agricultural Products, Fujian Province University, Fuzhou, Fujian 350002, China. Electronic address: hetonglin@163.com. (4)Institute of Postharvest Technology of Agricultural Products, College of Food Science, Fujian Agriculture and Forestry University, Fuzhou, Fujian 350002, China; Key Laboratory of Postharvest Biology of Subtropical Special Agricultural Products, Fujian Province University, Fuzhou, Fujian 350002, China. Electronic address: harris2197395@163.com. The influences of 150 μmol/L melatonin treatment on the quality properties, storability, and energy metabolism in carambola fruit were explored. The results showed that, compared to the control, melatonin treatment significantly retained higher rate of commercially acceptable fruit, and retarded the development of fruit browning and yellowing. Additionally, melatonin treatment displayed higher levels of chromaticity L⁎ and h° values, titratable acid, total soluble solids, total soluble sugars, sucrose, and vitamin C, but lower respiration rate, chromaticity a⁎ and b⁎ values, and reducing sugar content. Moreover, melatonin treatment presented higher levels of ATP, ADP, and energy charge, as well as higher activities of H+-ATPase, Mg2+-ATPase, and Ca2+-ATPase in the membranes of vacuole, mitochondria, and plasma, thereby reducing the damage to cell membranes. These results will provide a scientific basis and practical guidance for melatonin to maintain the quality properties and storability, and to prolong the shelf life of postharvest carambola fruit. Copyright © 2024 Elsevier Ltd. All rights reserved. DOI: 10.1016/j.foodchem.2024.141661 PMID: 39503091 Conflict of interest statement: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.